DXVX Increases Stake in Hanmi Science to 13.65%; Special Relations Control 15.70% Through Contracts; New Block Sale by Key Shareholder Agreed at 48,000 KRW per Share
DX & VX acquired an additional 151,109 common shares of Hanmi Science through open market purchases from April to May 2026, increasing its direct stake from 13.43% to 13.65%, funded by 5.4 billion KRW of internal reserves.
Including shares under pledge contracts repurchase agreements and stock lending arrangements, the total shares under major contracts held by the filer and its special relations reached 10,734,364 shares or 15.70% of outstanding shares up 3.07 percentage points from the prior report indicating expanded effective control.
Special relation Im Jong-hoon entered into a stock purchase agreement on June 29 2026 to sell 1,709,788 shares at 48,000 KRW per share totaling 82.1 billion KRW to Now IB 22 Fund with settlement scheduled for August 5 2026.
The reporting purpose is to exercise influence over management matters as defined in Article 154 of the Capital Markets Act suggesting ongoing active engagement in Hanmi Science's decision-making.
[AI Summary]DXVX's incremental open market purchases and complex contractual holdings underscore a strategic push for management influence at Hanmi Science. The large block sale by Im Jong-hoon to an external fund introduces a new variable in shareholder dynamics while no direct dilution or capital structure change occurs for Hanmi Science itself.